1 domain / 2 areas / 1 specialization
Dr. Bronner's
Data updated
Mission-driven company with publicly documented donations and advocacy support for psychedelic research and policy reform initiatives.
Foundations & Philanthropy Snapshot
Grant-Making OrganizationsClassification
Corporate Philanthropy Program
Geography
National
Coverage
Coverage not set
Last Verified
Apr 10, 2026
Funding Focus Areas
Support Types
Philanthropy Notes
Public statements by leadership document ongoing psychedelic-policy and psychedelic-health related philanthropy and advocacy partnerships.
Verification
Verified
Psychedelic Focus
Explicit Psychedelic Focus
Engagement Status
Active
Recorded Funding Activities
Multidisciplinary Association for Psychedelic Studies (MAPS)
Apr 17, 2017
donation - $5 million pledge for MDMA-assisted psychotherapy research for PTSD - $5 million ($1 million per year for five years)
Described by the company as its largest gift to an NGO partner at the time; funded MAPS' Phase 3 MDMA-assisted psychotherapy clinical trials.
Why We're Donating $5 Million to MAPS - Dr. Bronner'sMultidisciplinary Association for Psychedelic Studies (MAPS)
Sep 9, 2020
donation - $10 million pledge for psychedelic public education and advocacy (Heal Soul campaign) - $10 million (over ten years)
Announced by David Bronner (Cosmic Engagement Officer). Supports public education/advocacy around MDMA and psychedelic-assisted therapy via the Heal Soul campaign.
Lucid News: Why Dr. Bronner's is Donating $10 Million to MAPS for MDMA ResearchQuick Facts
- Website
- Visit